have been treated with
SPINRAZA worldwide1*

there’s someone from almost every
age group has taken
SPINRAZA2,3

have been treated with
SPINRAZA worldwide1*

*Based on commercial patients, early access patients, and clinical trial participants through May 2022.1
SPINRAZA pivotal studies included patients from 3 days to 16 years of age at first dose and did not include sufficient numbers of subjects aged 65 and older to determine whether they respond differently from younger patients.2

Considering SPINRAZA for your patient? Find resources for insurance, financial assistance, and more